{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458271906
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = [[CD25]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 152981-31-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Inolimomab''' is a [[mouse]] [[monoclonal antibody]] developed as an [[immunosuppressive drug]] against [[graft-versus-host disease]]. Its target is the [[CD25|alpha chain]] of the [[interleukin-2 receptor]].<ref name="pmid17085306">{{cite journal  |vauthors=Piñana JL, Valcárcel D, Martino R, etal |title=Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease |journal=Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation |volume=12 |issue=11 |pages=1135–41 |date=November 2006 |pmid=17085306 |doi=10.1016/j.bbmt.2006.06.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(06)00453-8}}</ref><ref>{{Cite journal 
| pmid = 17465640 
| year = 2007 
| last1 = Dartois | first1 = C.  | first2 = G. | first3 = M. | first4 = E. | first5 = B. | first6 = I. | first7 = C. | first8 = B. | first9 = P. 
| title = Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease 
| volume = 46 
| issue = 5 
| pages = 417–432
| pmc = 2760126 
| journal = Clinical pharmacokinetics 
| doi = 10.2165/00003088-200746050-00004 
| last2 = Freyer 
| last3 = Michallet 
| last4 = Hénin 
| last5 = You 
| last6 = Darlavoix 
| last7 = Vermot-Desroches 
| last8 = Tranchand 
| last9 = Girard
}}</ref>

==References==
{{Reflist}}

{{Immunosuppressants}}
{{Monoclonals for immune system}}
{{Interleukin receptor modulators}}

[[Category:Monoclonal antibodies]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}